Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Shares Outstanding (Weighted Average): 2020-2021

Historic Shares Outstanding (Weighted Average) for Design Therapeutics (DSGN) over the last 1 years, with Dec 2021 value amounting to $55.7 million.

  • Design Therapeutics' Shares Outstanding (Weighted Average) rose 3.43% to $55.7 million in Q4 2021 from the same period last year, while for Sep 2021 it was $55.6 million, marking a year-over-year change of. This contributed to the annual value of $56.6 million for FY2024, which is 1.11% up from last year.
  • As of Q4 2021, Design Therapeutics' Shares Outstanding (Weighted Average) stood at $55.7 million, which was up 0.08% from $55.6 million recorded in Q3 2021.
  • Design Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $55.7 million for Q4 2021, and its period low was $53.8 million during Q4 2020.
  • For the 2-year period, Design Therapeutics' Shares Outstanding (Weighted Average) averaged around $54.9 million, with its median value being $55.6 million (2021).
  • Data for Design Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY increased of 3.43% (in 2021) over the last 5 years.
  • Over the past 2 years, Design Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $53.8 million in 2020, then grew by 3.43% to $55.7 million in 2021.
  • Its last three reported values are $55.7 million in Q4 2021, $55.6 million for Q3 2021, and $55.6 million during Q2 2021.